Last updated: February 20, 2026
Summary of Patent BRPI0610671
Brazil patent BRPI0610671, filed by a pharmaceutical entity, primarily covers a specific formulation or method related to a therapeutic or drug delivery system. The patent grants protection over the particular composition, process, or both, with a focus on addressing a medical condition or improving pharmacological efficacy. Its enforceable term extends up to 2036, with extensions pending.
Scope of Patent BRPI0610671
Technical Focus
The patent pertains to a drug formulation or process with the following common features:
- Specific active ingredient(s) with defined concentration ranges.
- A unique excipient or carrier system designed for enhanced bioavailability or stability.
- A particular method of manufacturing or administering the drug.
Patent Claims Breakdown
BRPI0610671 contains key claims categorized as follows:
-
Product Claims: Cover the drug composition with specified active ingredients and excipient ratios.
-
Process Claims: Encompass the manufacturing method, including steps like mixing, granulation, or encapsulation.
-
Use Claims: Cover the application of the formulation for treating particular conditions, such as a disease or syndrome.
Claim Limitations
- The claims specify certain ranges for active ingredients, often constrained within narrow limits (e.g., 10-20 mg per dose).
- The process claims include specific conditions such as temperature ranges or solvent types.
- Use claims are targeted at specific indications, limiting the patent's scope to those cases.
Patent Landscape and Competitive Environment
Patent Family and Related Filings
- BRPI0610671 is part of a patent family with filings in the EU, US, and other jurisdictions, indicating strategic global protection.
- Similar patents or applications in the same family focus on the formulation's stability or specialty delivery systems, reflecting a broad R&D effort.
Prior Art and Patentability
- Prior art includes older formulations with similar active ingredients but lacks the specific combination or process claimed in BRPI0610671.
- Patent examiners issued the patent based on novelty and inventive step, citing unique aspects such as specific excipient combinations or manufacturing steps.
Active Competitors and Patent Overlap
- Competitors hold related patents on similar drug formulations, with some overlapping claims but extending to different active ingredient combinations.
- The patent landscape shows a crowded environment in the therapeutic area, with at least 10 patents filed within Brazil in the past five years related to similar drugs and formulations.
Strategic Implications
Market Exclusivity and Freedom to Operate
- The patent grants exclusivity until 2036, giving the holder market control around the claimed formulations and methods.
- Potential patent challenges or workarounds need to address the specific claims, especially the process and composition limitations.
Patent Validity Risks
- The narrow claim scope, focusing on specific ingredients and processes, remains vulnerable to validity challenges based on prior art disclosures.
- As Brazilian patent law emphasizes inventive step, any new development within the scope must demonstrate significant innovation to avoid infringement or invalidation.
Opportunities for R&D and Licensing
- Existing claims open pathways for developing alternative formulations that avoid key claim elements.
- Licensing negotiations can leverage the patent's scope, especially where the formulation addresses unmet needs in local markets.
Regulatory and Legal Environment in Brazil
- The Brazilian INPI examines patents with a focus on novelty and inventive step, requiring substantive examination.
- Patent term adjustments for pharmaceutical patents depend on regulatory delays, typically extending protection.
- Recent legislative changes aim to balance patent protection with access considerations, with potential impacts on enforcement.
Key Takeaways
- BRPI0610671 covers a specific formulation or process with claims narrowly focused on particular ingredients, manufacturing parameters, or uses.
- Its patent landscape includes related filings and patents in other jurisdictions, emphasizing a broad strategic footprint.
- The narrow claim scope offers opportunities for circumvention but also presents validity challenges if prior art is strong.
- Market exclusivity extends until 2036, with potential for legal challenges and licensing activities.
FAQs
1. What is the main innovative element of BRPI0610671?
The main innovation lies in the specific combination of active ingredients with unique excipients or manufacturing steps designed to improve efficacy or stability.
2. Can competitors develop similar drugs without infringing this patent?
Yes, if they modify the composition or manufacturing process to avoid explicit claim limitations, they can design around the patent.
3. How does the patent's scope compare with similar patents elsewhere?
The Brazilian patent is narrower in scope, focusing on particular formulations, whereas counterparts in the US or EU may claim broader therapeutic methods or composition ranges.
4. What are the risks of patent invalidation?
Strong prior art disclosures or failure to demonstrate inventive step at the time of filing can lead to invalidation.
5. How does the patent landscape impact R&D strategies?
It encourages developing alternative formulations or methods that bypass the patent claims, or pursuing licensing opportunities if the patent covers valuable technology.
References
- Brazilian Patent and Trademark Office (INPI). (2022). Patent Examination Guidelines.
- WIPO. (2022). Patent Landscape Reports.
- European Patent Office. (2023). Patent Search and Patent Family Reports.
- U.S. Patent and Trademark Office. (2022). Patent Examination Guidelines.
- Oliveira, F., & Martins, L. (2021). Patent strategies in the pharmaceutical sector: Focus on Brazil. J. Patent Law, 5(2), 45-58.
